Cardiovascular Mortality

An analysis of DAPA-CKD data showed dapagliflozin reduces the risk for kidney failure and mortality in patients with advanced chronic kidney disease, a subgroup that made up 14% of the study population included in the initial trial.

Elevated serum copper levels were associated with CVD mortality risk in men, especially those with obesity, according to findings presented at the virtual American Society for Preventive Cardiology Congress on CVD Prevention.

Adults with upward wealth mobility in late middle age had reduced risk for CV events or death after age 65 years, researchers reported in JAMA Cardiology.

Heart disease remains the leading cause of death globally, according to recent statistics, putting the spotlight on prevention and eliminating race and sex disparities.

The addition of androgen deprivation therapy to radiation therapy did not appear associated with an increased risk for cardiovascular mortality among men with prostate cancer, according to a study published in Cancer.

The SCAI shock classification system may provide mortality risk stratification of patients at risk for or who experienced cardiogenic shock, a speaker reported.

Among patients with HF with reduced ejection fraction, elevated N-terminal pro-B-type natriuretic peptide level was associated with greater risk for HF hospitalization and CV mortality, regardless of BMI, researchers reported.

Among veterans with HIV and new-onset hypertension, beta-blockers were independently associated with increased risk for incident CVD or death compared with ACE inhibitors or angiotensin receptor blockers, researchers reported.

Even small increases in nitrogen dioxide in the air may increase the risk for cardiovascular and respiratory mortality, according to new data published in The BMJ.

Among patients with CVD, influenza vaccination was associated with lower risk for all-cause and CV death and major adverse CV events compared with no vaccination, according to a meta-analysis.